Drug data last refreshed Yesterday
Oxytocin is a synthetic hormone injection used to treat postpartum hemorrhage by stimulating uterine contractions. It works by acting on smooth muscle receptors in the uterus to increase the frequency and tone of contractions, particularly effective in the immediate postpartum period. The drug has been approved since 1980 and remains a critical intervention in obstetrics.
Product lifecycle approaching loss of exclusivity with moderate competitive pressure (30), indicating potential team rightsizing and focus on cost management and market share defense.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
Oxytocin Effects on Bone in Children With Autism Spectrum Disorder
Oxytocin on Cold Water Task Performance and Recovery
Worked on OXYTOCIN at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Hikma is hiring 10 roles related to this product
Working on oxytocin offers stable career positioning in a critical maternal health indication with established clinical need and market presence. However, the LOE-approaching lifecycle and zero linked job openings indicate limited growth opportunity and potential team contraction, making this product attractive primarily for professionals seeking established markets rather than growth trajectories.